Resynchronizing a dyssynchronous failing heart — coronary-sinus LV lead placement and AV/VV interval tuning
Roughly a third of patients with heart failure and reduced ejection fraction (HFrEF) also carry a left bundle branch block (LBBB) — a delay or block in the His-Purkinje conduction down the left bundle. Electrical delay becomes mechanical dyssynchrony: the septum and the lateral wall of the left ventricle no longer contract together, and the heart wastes energy fighting itself instead of ejecting blood.
Normal ventricular activation travels down the His bundle and splits into right and left bundle branches almost simultaneously, so both ventricles — and the septal and lateral walls of the left ventricle — depolarize together within about 60–90 ms.
In LBBB, conduction down the left bundle is blocked. The impulse must instead travel down the right bundle, activate the right ventricle, and then cross the septum cell-by-cell (slow myocyte-to-myocyte conduction rather than fast Purkinje conduction) to finally reach the lateral and postero-lateral LV wall. This adds 40–100 ms of extra activation time, producing the characteristic wide, notched QRS complex (typically >150 ms, often >180 ms in advanced cases) seen on the surface ECG.
The net effect: the septum contracts early — while the lateral wall is still relaxed and unable to generate opposing pressure — then relaxes just as the lateral wall belatedly contracts against a septum that is no longer stiff. This creates a "rocking" or "bowing" motion of the septum, visible on echocardiography as septal flash and apical rocking.
Dyssynchrony is not just electrical — it is mechanically wasteful. Septal pre-stretch and post-systolic lateral wall shortening mean a portion of every stroke volume is spent stretching myocardium rather than ejecting blood, directly lowering the ejection fraction independent of underlying contractility.
Chronic dyssynchrony has consequences beyond a single wasted heartbeat:
• Reduced stroke volume and ejection fraction — uncoordinated contraction lowers the pressure generated during systole for a given amount of contractile tissue • Functional mitral regurgitation — asynchronous papillary muscle activation delays mitral leaflet coaptation, allowing regurgitant flow • Prolonged isovolumic contraction and relaxation times — less time is spent in efficient ejection and filling • Adverse remodeling — the chronically overworked, asymmetrically loaded septum and lateral wall progressively dilate and fibrose, worsening the underlying cardiomyopathy in a self-reinforcing cycle
This is the rationale for cardiac resynchronization therapy (CRT): if dyssynchrony itself is contributing meaningfully to pump failure, then correcting the timing — not just the electrical substrate but the mechanical sequence of contraction — can improve hemodynamics without any new drug or a new heart.
Major society guidelines (ACC/AHA/HRS, ESC) converge on a core CRT population:
• LVEF ≤35% despite guideline-directed medical therapy • QRS duration ≥150 ms, LBBB morphology — the strongest predictors of benefit • NYHA functional class II–IV symptoms • Sinus rhythm (though atrial fibrillation with AV-node ablation is also treated)
Patients with QRS 120–149 ms or non-LBBB morphology (e.g., right bundle branch block or nonspecific intraventricular conduction delay) derive smaller, less certain benefit — LBBB morphology and wider QRS are consistently the best predictors of a robust echocardiographic and clinical response to resynchronization.
Unlike the right-heart chambers, the left ventricle has no direct venous access from the systemic veins — so the LV lead cannot simply be pushed through a vein into the LV cavity. Instead, implanters thread the lead retrogradely through the coronary sinus and out into one of its epicardial tributary veins, pacing the LV wall from the outside of the heart.
The coronary sinus (CS) is the terminal, dilated venous channel that drains most of the heart's venous blood into the right atrium via the CS ostium, located postero-septally near the tricuspid valve annulus and often guarded by a thebesian valve. From the CS, several named tributary veins fan out over the LV epicardial surface:
• Great cardiac vein — runs in the anterior interventricular groove, continues as the CS • Postero-lateral vein — drains the LV lateral and postero-lateral wall — the preferred CRT target, usually overlying the latest-activated myocardium in LBBB • Middle cardiac vein — runs in the posterior interventricular groove, drains the inferior wall • Anterior interventricular vein — drains the anterior wall, rarely first choice
Because the postero-lateral and lateral walls are typically the last to activate in LBBB, a lead placed in the postero-lateral vein paces the myocardium that most needs an earlier, custom-timed stimulus.
1. A specialized CS guiding sheath (with a deflectable or pre-shaped catheter) is advanced from a subclavian or axillary venous access into the right atrium and steered to engage the CS ostium — often the most technically demanding step of the whole implant.
2. Once inside the CS, a balloon-tipped venography catheter is advanced and the balloon inflated to occlude retrograde flow; contrast is injected to opacify the entire venous tree on fluoroscopy ("occlusive venogram"), revealing the number, caliber, and course of available tributary veins.
3. A soft guidewire is navigated into the chosen tributary vein (postero-lateral preferred), and the LV lead — thin, unipolar-to-quadripolar, without a fixation screw — is advanced over the wire until its pacing electrodes sit in a stable, non-phrenic-nerve-stimulating position.
4. Pacing thresholds, phrenic nerve capture (diaphragmatic stimulation must be excluded), and R-wave sensing are tested before the wire is withdrawn and the sheath is slit and peeled away, leaving the lead in place.
Quadripolar LV leads (four electrodes along the lead body) let the implanter choose among multiple pacing vectors after implantation — reprogramming which electrode pair paces the LV without ever repeating the procedure, and often solving phrenic nerve stimulation or high-threshold problems non-invasively in clinic.
In roughly 5–10% of patients, CS cannulation is unsuccessful, or no acceptable tributary vein is available (absent CS, prior cardiac surgery scarring, small-caliber or tortuous veins, phrenic nerve stimulation at every site). Alternatives include:
• Surgical epicardial LV lead placement via minithoracotomy — direct suture-on lead onto the LV epicardium • Endocardial LV lead placement via transseptal puncture — pacing from inside the LV cavity, higher stroke/thromboembolism risk, reserved for select cases • Conduction system pacing (His-bundle or left bundle branch area pacing) as an alternative resynchronization strategy entirely bypassing the coronary sinus — discussed further in Stage 5
A conventional CRT-P (pacemaker) or CRT-D (defibrillator) device places three leads: one in the right atrium for atrial sensing and tracking, one in the right ventricular apex or septum, and one in a coronary sinus branch overlying the LV lateral wall. Together they let the device pre-empt the heart's own dyssynchronous conduction with a programmed, synchronized biventricular pacing sequence.
• RA lead — placed in the right atrial appendage or septum; senses intrinsic atrial activity (or paces it) and provides the timing reference that starts the AV delay countdown
• RV lead — placed at the right ventricular apex or, increasingly, the interventricular septum; paces the right ventricle and, in CRT-D devices, doubles as the defibrillation coil for sudden cardiac death protection
• LV lead — the CS-branch lead placed in Stage 2; paces the LV lateral/postero-lateral wall from the epicardial surface
The device times its RV and LV pacing stimuli relative to the sensed or paced atrial event, delivering both ventricular stimuli within milliseconds of each other (biventricular pacing) so the septum and lateral wall are activated together instead of 50–100 ms apart.
Naively, one might pace RV and LV at exactly the same instant (VV offset = 0). In practice, because the LV lead paces epicardially (outside-in conduction, inherently slower to depolarize the full LV wall thickness than endocardial Purkinje-mediated conduction) and because native residual conduction still contributes in many patients, a small VV offset — often LV pre-activation by 0–40 ms — better re-creates truly simultaneous septal and lateral wall mechanical contraction than a nominal VV=0 setting.
This is why VV offset is a programmable, patient-specific parameter rather than a fixed default, and why the optimization step (Stage 4) is a clinically meaningful part of CRT care, not an afterthought.
CRT only helps during beats that are actually biventricularly paced. Any competing intrinsic conduction (frequent premature ventricular contractions, atrial fibrillation with rapid conduction, inadequate AV delay programming that lets native conduction "beat the pacemaker to it") reduces effective CRT delivery.
Outcome studies consistently show that patients achieving ≥98% biventricular pacing have substantially better survival and reverse-remodeling than those at 90–95%, even though both figures sound high — reinforcing that device programming and rhythm control are inseparable from lead placement in determining whether a patient truly receives the therapy.
Placing the leads correctly is necessary but not sufficient. The atrioventricular (AV) delay — the time from sensed/paced atrial activity to ventricular pacing — and the interventricular (VV) offset — the relative timing between RV and LV stimuli — must be tuned to each patient's own conduction and hemodynamics to convert anatomically correct lead placement into true electromechanical resynchronization.
The AV delay must be short enough to ensure full ventricular capture on every beat (pre-empting intrinsic conduction), but long enough to preserve the atrial contribution to LV filling (the "atrial kick") — an AV delay that is too short truncates the mitral A-wave and can even close the mitral valve before atrial systole finishes, worsening diastolic filling.
Echo-guided optimization (e.g., the iterative Ritter method using mitral inflow Doppler) sweeps the programmed AV delay and identifies the value that produces the longest diastolic filling time without truncating the A-wave — typically landing in the 100–150 ms range, though individual variation is substantial. Algorithmic (device-based, electrogram-derived) optimization methods are also widely used and avoid the time cost of a dedicated echo study.
The VV offset shifts the relative timing between the RV and LV pacing stimuli. Because epicardial LV pacing is inherently slower to fully depolarize the ventricular wall than endocardial RV pacing, pre-activating the LV by roughly 0–40 ms (a negative VV offset in most device conventions) frequently produces more truly simultaneous mechanical contraction than firing both stimuli at once.
Optimization targets include: • Narrowest paced QRS duration on 12-lead ECG • Maximal LV dP/dt (rate of pressure rise) by invasive catheter or non-invasive surrogate • Minimal septal-to-lateral wall mechanical delay by tissue Doppler or speckle-tracking echocardiography • Maximal aortic velocity-time integral (a stroke-volume surrogate) by Doppler echo
Multiple randomized trials (e.g., SMART-AV, RESPONSE-HF) found that routine echo-guided AV/VV optimization does not clearly outperform simple nominal or device-automated settings at the population level — yet in individual patients with a suboptimal empirical response, dedicated optimization can meaningfully improve hemodynamics. Optimization is best viewed as a tool for troubleshooting non-responders, not a mandatory step for every implant.
A successfully resynchronized paced QRS is not just narrower than the baseline LBBB QRS — its morphology changes qualitatively. The paced complex typically shows a dominant R-wave in lead V1 (reflecting the fused wavefronts from RV septal/apical and LV lateral pacing sites reaching the septum from opposite directions) and an overall duration reduction of roughly 20–40% from the pre-implant baseline in good responders. Failure of the paced QRS to narrow at all despite confirmed biventricular capture is itself a warning sign of a poor lead position or inadequate scar-avoidance, and often prompts LV lead revision.
The ultimate test of CRT is not the paced QRS width but whether the heart pumps better and the patient feels and lives better. Roughly two-thirds of appropriately selected patients show a meaningful "responder" improvement in ejection fraction, symptoms, and reverse remodeling — while a substantial minority do not, motivating both careful patient selection and newer resynchronization strategies like conduction system pacing.
The left ventricular pressure-volume (PV) loop plots LV pressure against LV volume across a single cardiac cycle; its enclosed area equals the external stroke work performed by that beat. In dyssynchronous failing hearts, the loop is narrow and shifted rightward — a dilated, high end-diastolic-volume ventricle generating disproportionately little pressure and ejecting a small stroke volume (low ejection fraction).
With optimized biventricular pacing, the loop widens: peak systolic pressure and dP/dt rise, end-systolic volume falls (the ventricle empties more completely), and stroke volume and ejection fraction both increase — without any change in the heart's intrinsic contractile protein biology. The improvement comes purely from restoring coordinated, efficient mechanical activation.
In invasive hemodynamic studies, switching from intrinsic dyssynchronous conduction to optimized biventricular pacing can acutely raise LV dP/dt-max by 15–25% and stroke work by a comparable margin — within seconds of turning the device on, before any structural reverse remodeling has had time to occur.
Roughly 30–40% of CRT recipients are classified as non-responders (typically defined as <15% reduction in LV end-systolic volume, or no meaningful symptomatic/functional improvement at 6–12 months). Recognized contributors include:
• Extensive myocardial scar at or near the LV lead pacing site — scar cannot be electrically or mechanically "resynchronized" • Suboptimal LV lead position — anterior or apical position instead of the ideal postero-lateral, latest-activated site • Inadequate percent biventricular pacing — competing intrinsic conduction, frequent ectopy, or uncontrolled atrial fibrillation • Non-LBBB conduction pattern or QRS <150 ms at baseline — smaller electrical substrate to correct • Severe irreversible cardiomyopathy where dyssynchrony was only a minor contributor to pump failure
Non-response prompts systematic troubleshooting: confirm capture and percent-pacing on device interrogation, consider LV lead revision to a better vein/pacing vector, reassess AV/VV programming, and treat any modifiable arrhythmia.
His-bundle pacing and left bundle branch area pacing deliver the pacing stimulus directly into or adjacent to the native conduction system, aiming to recruit the heart's own fast Purkinje network rather than relying on slow, epicardial cell-to-cell spread from a coronary sinus branch lead.
• His-bundle pacing captures the His bundle itself, in principle restoring fully physiological, near-normal QRS activation — but technically challenging with higher and sometimes unstable pacing thresholds and a risk of losing capture over time • Left bundle branch area pacing (LBBAP) — a lead is screwed transventricularly through the septum to capture the left bundle branch or nearby conduction fascicles — has emerged as a more technically reproducible option with excellent, stable thresholds and increasing use as either a primary resynchronization strategy or a rescue option when coronary sinus access fails
Head-to-head randomized trials comparing conduction system pacing against conventional biventricular CRT are ongoing; early and observational data suggest at least comparable, and in some non-responder or CS-access-failure populations superior, electrical and echocardiographic resynchronization — positioning conduction system pacing as a genuine and growing alternative rather than a purely investigational technique.